1. DOP007 Efficacy of vedolizumab induction therapy on clinical and endoscopic activity in patients with anti-tumour necrosis factor alpha-resistant inflammatory bowel disease. (16th January 2018) Authors: Bor, R; Klaudia, F; Miheller, P; Palatka, K; Szamosi, T; Vincze, Á; Rutka, M; Szántó, K; Bálint, A; Szepes, Z; Nagy, F; Milassin, Á; Fábián, A; Csontos, Á; Golovics, P; Lakner, L; Müllner, K; Papp, M; Salamon, Á; Sarang, K Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S034 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DOP13 Plasma metabolite fingerprint could discriminate inflammatory bowel disease patients from healthy subjects. (30th January 2023) Authors: Farkas, K; Endre, G; Bacsur, P; Resál, T; Kocsmárszky-Koósz, V; Tömösi, F; Tóth, E; Rutka, M; Bálint, A; Fábián, A; Bor, R; Szepes, Z; Goretity, Á; Thibodeau, I; Molnár, T Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P279 Prevalence of iron deficiency in inflammatory bowel disease. (21st January 2022) Authors: Resál, T; Bacsur, P; Lupas, D; Szántó, K; Rutka, M; Fábián, A; Bor, R; Szepes, Z; Farkas, K; Varga, M; Molnár, T Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i313 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P309 Accuracy of PanMayo endoscopic score in predicting long-term disease outcomes in ulcerative colitis– a promising scoring system. (30th January 2023) Authors: Bacsur, P; Wetwittayakhlang, P; Resál, T; Rutka, M; Bessissow, T; Atif, W; Bálint, A; Fábián, A; Bor, R; Szepes, Z; Farkas, K; Lakatos, P L; Molnár, T Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i451 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P352 Ustekinumab is associated with superior treatment persistence compared to vedolizumab in Crohn's disease patients who failed to anti-TNF therapy: results from a Hungarian cohort study. (21st January 2022) Authors: Bacsur, P; Resál, T; Miheller, P; Szamosi, T; Schäfer, E; Sarlós, P; Iliás, Á; Szántó, K J; Rutka, M; Bálint, A; Fábián, A; Bor, R; Zoltán, S; Matuz, M; Molnár, T; Farkas, K Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i364 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P371 Outcome of immediate infliximab optimisation based on rapid assessment of serum drug and faecal calprotectin concentrations in Crohn's disease. (25th January 2019) Authors: Farkas, K; Szántó, K; Kata, D; Bálint, A; Milassin, Á; Fábián, A; Bor, R; Rutka, M; Szepes, Z; Soós, I; Nagy, F; Földesi, I; Molnár, T Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S290 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P444 COVID-19 risk factors, infection course and vaccination among patients with inflammatory bowel disease based on a Hungarian cohort. (21st January 2022) Authors: Farkas, K; Matuz, M; Kata, D; Földesi, I; Resál, T; Bacsur, P; Szántó, K; Kolarovszki-Erdei, D; Rutka, M; Fábián, A; Bor, R; Szepes, Z; Sarlós, P; Miheller, P; Zacháry, A; Molnár, T Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i425 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P495 Does drug level monitoring help us to understand the mechanism behind the superiority of combo therapy in inflammatory bowel diseases?. (16th January 2018) Authors: Fábián, A; Szántó, K; Szíjártó, A L; Bor, R; Bálint, A; Farkas, K; Milassin, Á; Rutka, M; Szepes, Z; Földesi, I; Kata, D; Mezei, Z A; Lovas, S; Palatka, K; Molnár, T Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S356 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P534 IBD-related malignancies observed in 2015–2018: 4 years' results from the prospective nationwide Hungarian registry. (25th January 2019) Authors: Milassin, A; Rutka, M; Farkas, K; Bálint, A; Bor, R; Fábián, A; Szepes, Z; Szamosi, T; Szántó, K; Miheller, P; Barta, Z; Banai, J; Kovács, Á; Salamon, Á; Lakatos, L; Lakner, L; Palatka, K; Papp, M; Schafer, E; Novák, J Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S380 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P572 Therapy optimisation and intravenous ferric carboxymaltose in active or inactive IBD with iron deficiency: it's time to make iron deficiency part of tight monitoring to reach T2T? – preliminary results of a prospective study. (21st January 2022) Authors: Molnár, T; Resál, T; Bacsur, P; Rutka, M; Szántó, K; Bálint, A; Milassin, Á; Fábián, A; Bor, R; Szepes, Z; Farkas, K Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i513 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗